The Mechanism of Calcitriol in Cancer Prevention and Treatment

Jiguang Ma(First Affiliated Hospital of Xi'an Jiaotong University), Suxia Han(First Affiliated Hospital of Xi'an Jiaotong University), Jian Guo, Wěi Li(Shougang (China)), Rong Li(Kunming Medical University), Fengfei Wang(Yantai University), Qingyong Ma(First Affiliated Hospital of Xi'an Jiaotong University), Zhenhua Ma(Hainan Provincial Academy of Marine Fisheries and Aquaculture), Ang Hu(Sun Yat-sen University)
Current Medicinal Chemistry
September 1, 2013
10.2174/09298673113209990195
Cited by 9

Related Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
|The Lancet|2022|664
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416